Clinical Pharmaceutics
A section of Pharmaceutics (ISSN 1999-4923).
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Mesenchymal Stem/Stromal Cell-Based-Delivery for Clinical Applications (Deadline: 30 October 2024)
- Therapeutic Drugs and Delivery Strategies for Gastrointestinal Diseases (Deadline: 31 October 2024)
- Drug Design and Novel Biomarkers for the Treatment of Gastrointestinal Tumors (Deadline: 15 November 2024)
- In Vitro–In Vivo Correlation and Mechanistic Pharmacokinetic Models: Bridging Drug In Vitro Characteristics and In Vivo Behaviors (Deadline: 30 November 2024)
- Drug Monitoring of Antibiotics in the Era of Precision Dosing (Deadline: 31 December 2024)
- Extemporaneous Formulations: Filling the Gap in the Pharmaceutical Industry with Personalized Medicines (Deadline: 31 December 2024)
- Novel Therapeutic Strategies for Glioblastoma (Deadline: 31 December 2024)
- Unveiling New Insights and Treatment Options for Ocular Surface Diseases (Deadline: 31 December 2024)
- Advances in the Pharmaceutical Treatment of Cardiovascular Disease (Deadline: 10 January 2025)
- Strategies for the Next Generation of Antibody-Drug Conjugates: Utilizing Tumor Immunology and Microenvironmental Factors in ADC Design (Deadline: 20 January 2025)
- Pharmaceutical Compounding and Development of Advanced Therapy Medicinal Products: From Bench to Bedside (Deadline: 31 January 2025)
- Pharmaceutical Technology and Formulations for the Treatment of Eye Diseases (Deadline: 20 February 2025)
- Advances in Radiopharmaceuticals for Disease Diagnoses and Therapy (Deadline: 20 March 2025)